According to a recent LinkedIn post from Impress, the company has been included on Endeavor’s 2026 outliers list of “Spanish champions,” described as the top 10% of entrepreneurs in its global network across 45 countries. The post notes that Endeavor Spain’s framework emphasizes sustainable businesses with strong revenue growth and international competition rather than funding totals or unicorn valuations.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also relays that Impress is portrayed in the Endeavor article as the “largest invisible orthodontics network in Europe,” reportedly serving more than 250,000 patients annually across 10 countries. It attributes this scale to a model that combines AI technology with clinical care to increase doctor productivity and patient outcomes, with the company indicating it sees further room for expansion in addressable patient reach.
For investors, the recognition by Endeavor Spain suggests external validation of Impress’s growth profile and business fundamentals, with a focus on revenue and international operations rather than headline valuations. If accurate, the reported patient volume and multi-country footprint may indicate meaningful market share in European clear aligners and could support expectations for continued top-line growth, though the post does not disclose financial metrics or profitability.
The emphasis on AI-enabled care delivery points to a technology-driven operating model that could offer scalability and margin benefits if execution remains strong. At the same time, rapid cross-border expansion in health tech and orthodontics typically entails regulatory, clinical quality, and competitive risks, so the long-term financial impact will depend on Impress’s ability to maintain clinical standards and unit economics while growing its network.

